Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Toleriane Dermallergo Eye Cream
- Development stage
- Unknown
- Lead developer
- La Roche-Posay
- Modality
- Peptides
- Administration
- Topical
01
Overview
Toleriane Dermallergo Eye Cream is a specialized topical dermocosmetic treatment developed by La Roche-Posay for ultra-sensitive, allergy-prone, and eczema-prone skin in the periorbital region. The formulation is centered on two key active components: **Sphingobioma**, a postbiotic extract derived from *Vitreoscilla filiformis* grown in La Roche-Posay Thermal Spring Water, which helps to balance the skin microbiome and strengthen natural defenses; and **Neurosensine** (Acetyl Dipeptide-1 Cetyl Ester), a dipeptide that acts as a neuro-soothing agent to reduce signs of skin irritation, redness, and itching. The cream also incorporates niacinamide for its anti-inflammatory properties and shea butter to restore the skin's hydrolipidic film. It is frequently recommended for patients with atopic dermatitis, contact dermatitis, and those undergoing oncology treatments who experience skin toxicity.
- Brand names
- Toleriane Dermallergo Eye CreamLa Roche-Posay Toleriane Dermallergo Eye Cream
- Other names
- Toleriane Ultra Eye CreamToleriane Dermallergo Eyes
Beyond the preview
Go deeper on Toleriane Dermallergo Eye Cream.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Toleriane Dermallergo Eye Cream.